{
    "nctId": "NCT01315119",
    "briefTitle": "SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants",
    "officialTitle": "The Role of SPY Intra-Operative Angiography in Determining Adequate Skin Perfusion in Immediate Breast Reconstruction With Implants",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "To compare clinical visual assessment of skin viability with intraoperative SPY imaging.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n3.1.0 Ability to understand and the willingness to sign a written informed consent document.\n\n3.1.1 Signed written informed consent.\n\n3.1.2 Women with local or regional recurrences after previous breast conserving surgery.\n\n3.1.3 Women undergoing delayed post mastectomy reconstruction.\n\n3.1.4 Women undergoing prophylactic mastectomy.\n\n3.1.5 Women with invasive or non-invasive breast cancer, receiving breast conserving surgery with or without reduction mammoplasty or mastectomy, with or without immediate reconstruction.\n\n3.1.6 Women of 18 years of age or older.\n\n3.1.7 ECOG or Karnofsky Performance Status 0,1,2.\n\n3.1.8 Basic Metabolic Panel within 6 months\n\n3.1.9 Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements.\n\nExclusion Criteria:\n\n3.2.1 History of liver or kidney failure will not be eligible.\n\n3.2.2 Allergies to iodine containing products will not be eligible.\n\n3.2.3 Women who are pregnant will not be eligible.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}